Instead, PD-1 was upregulated in peripheral blood specimens of patients with AML who relapsed after either intensive chemotherapy or allogeneic stem cell transplantation (allo-SCT) compared with those of the same patients at the time of diagnosis. The gene discussed is PDCD1; the disease is acute myeloid leukemia.